Comparing Cobenfy vs Invega
| Cobenfy (trospium / xanomeline) | Invega (paliperidone) |
|
|---|
| Cobenfy (trospium / xanomeline) | Invega (paliperidone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Schizophrenia. Cobenfy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Schizoaffective Disorder, Schizophrenia. Invega may also be used for purposes not listed in this medication guide. |
Related suggestions Schizophrenia
|
|||||||||||||||
| More about Cobenfy (trospium / xanomeline) | More about Invega (paliperidone) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Cobenfy has an average rating of 6.0 out of 10 from a total of 4 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 25% reported a negative effect. |
Invega has an average rating of 4.8 out of 10 from a total of 234 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Cobenfy side effects |
View all Invega side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Cobenfy prices |
View all Invega prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other paliperidone brands include: Erzofri, Invega Hafyera, Invega Sustenna, Invega Trinza | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
6 hours |
23 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 386 drugs are known to interact with Cobenfy:
|
A total of 629 drugs are known to interact with Invega:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 26, 2024 |
December 19, 2006 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.